These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19837089

  • 1. Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates.
    Kitikoon P, Vincent AL, Janke BH, Erickson B, Strait EL, Yu S, Gramer MR, Thacker EL.
    Vaccine; 2009 Dec 11; 28(2):523-31. PubMed ID: 19837089
    [Abstract] [Full Text] [Related]

  • 2. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
    Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME, Roth JA.
    Vaccine; 2011 Mar 24; 29(15):2712-9. PubMed ID: 21310191
    [Abstract] [Full Text] [Related]

  • 3. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL.
    Vet Immunol Immunopathol; 2006 Aug 15; 112(3-4):117-28. PubMed ID: 16621020
    [Abstract] [Full Text] [Related]

  • 4. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA.
    Vet Microbiol; 2008 Jan 25; 126(4):310-23. PubMed ID: 17719188
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
    Vincent AL, Ciacci-Zanella JR, Lorusso A, Gauger PC, Zanella EL, Kehrli ME, Janke BH, Lager KM.
    Vaccine; 2010 Mar 24; 28(15):2782-7. PubMed ID: 20132919
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.
    Ferrari M, Borghetti P, Foni E, Robotti C, Di Lecce R, Corradi A, Petrini S, Bottarelli E.
    Zoonoses Public Health; 2010 Jun 24; 57(4):273-80. PubMed ID: 19538454
    [Abstract] [Full Text] [Related]

  • 7. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV, Brown I, Essen S, Pensaert M.
    Virus Res; 2004 Jul 24; 103(1-2):115-24. PubMed ID: 15163499
    [Abstract] [Full Text] [Related]

  • 8. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
    Kitikoon P, Vincent AL, Jones KR, Nilubol D, Yu S, Janke BH, Thacker BJ, Thacker EL.
    Vet Microbiol; 2009 Nov 18; 139(3-4):235-44. PubMed ID: 19595522
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
    Kitikoon P, Strait EL, Thacker EL.
    Vet Microbiol; 2008 Jan 01; 126(1-3):51-62. PubMed ID: 17719187
    [Abstract] [Full Text] [Related]

  • 12. Evidence of the concurrent circulation of H1N2, H1N1 and H3N2 influenza A viruses in densely populated pig areas in Spain.
    Maldonado J, Van Reeth K, Riera P, Sitjà M, Saubi N, Espuña E, Artigas C.
    Vet J; 2006 Sep 01; 172(2):377-81. PubMed ID: 15914047
    [Abstract] [Full Text] [Related]

  • 13. Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.
    Platt R, Vincent AL, Gauger PC, Loving CL, Zanella EL, Lager KM, Kehrli ME, Kimura K, Roth JA.
    Vet Immunol Immunopathol; 2011 Aug 15; 142(3-4):252-7. PubMed ID: 21664701
    [Abstract] [Full Text] [Related]

  • 14. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.
    Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C.
    Vaccine; 2012 Apr 26; 30(20):3119-25. PubMed ID: 22391400
    [Abstract] [Full Text] [Related]

  • 15. Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam.
    Takemae N, Nguyen T, Ngo LT, Hiromoto Y, Uchida Y, Pham VP, Kageyama T, Kasuo S, Shimada S, Yamashita Y, Goto K, Kubo H, Le VT, Van Vo H, Do HT, Nguyen DH, Hayashi T, Matsuu A, Saito T.
    Arch Virol; 2013 Apr 26; 158(4):859-76. PubMed ID: 23435952
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.
    Said A, Lange E, Beer M, Damiani A, Osterrieder N.
    Virus Res; 2013 May 26; 173(2):371-6. PubMed ID: 23333290
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS, Gramer MR, Barbé F, Van Doorsselaere J, Van Reeth K.
    Vet Microbiol; 2010 Jul 29; 144(1-2):67-74. PubMed ID: 20116942
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
    Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME, Roth JA.
    Vet Pathol; 2012 Nov 29; 49(6):900-12. PubMed ID: 22461226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.